3
2
1

DFT Empowers the Research and Development of Cryoprotectants, Offering New Strategies for Biological Cryopreservation

Release time:

2025-07-11

A Russian research team has recently published a groundbreaking achievement. By combining density functional theory (DFT) calculations with experimental verification, they successfully uncovered the molecular mechanism of sucrose molecules in cryopreservation, presenting a brand - new strategy for optimizing the freeze - drying process of biological samples and for biological cryopreservation. This research not only resolves the long - standing problem of ice - crystal damage that has troubled cryobiology but also initiates an interdisciplinary research paradigm of "theoretical calculations guiding experimental design".

In the field of biological sample cryopreservation, cell damage caused by ice - crystal formation has always been the core challenge. Traditional cryoprotectants like dimethyl sulfoxide (DMSO) can lower the freezing point, yet they carry the risk of toxicity. Moreover, the selection of sugar - based cryoprotectants lacks a scientific basis. The Russian team innovatively employed DFT calculations to precisely analyze the hydrogen - bonding mechanism of molecules such as sucrose at the B3LYP - D3/def2 - SVP theoretical level. The study found that the dense hydroxyl groups in sucrose molecules can form a stronger hydrogen - bonding network (with a bond energy of 25 - 30 kJ/mol) than pure water, creating a stable and dynamic hydration shell that effectively inhibits ice - crystal growth.

 

Experimental verification showed that the survival rate of Bacillus coagulans and Streptococcus thermophilus treated with a 12% sucrose solution increased by three times under cryopreservation conditions from - 18°C to - 80°C. The research team further optimized the gradient - cooling procedure. Smaller ice crystals formed at - 18°C can reduce mechanical damage, and rapid transfer to - 80°C effectively suppresses ice - crystal recrystallization. This two - step freezing method has been successfully applied in Russian industrial microbial culture collections, significantly increasing the survival rate of microbial strains. In the future, it is expected to be extended to the cryopreservation of stem cells and vaccines.

 

This is the first time that DFT electron - density analysis has been applied to the screening of cryoprotectants. Professor Michael Nosonovsky, the corresponding author of the paper, stated, "DFT calculations are like GPS navigation in cryobiology. They enable us to quickly identify the optimal cryoprotection strategy in the complex maze of molecular interactions."

Experts believe that this study, published in Cryobiology, adds an important theoretical foundation to the field of cryoprotection mechanism research and is of milestone significance. The application of DFT theory will accelerate the development of low - toxicity and high - efficiency cryoprotectants and is expected to be extended to the cryopreservation of high - value biological materials such as stem cells and vaccines in the future. With the rapid development of computational biology, this technology may become the core technology for long - term biological sample preservation.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.